Is Defibrinoside/Defibrinated Sodium effective?

Defibrotide/Defibrotide (Defibrotide) is a drug used to treat hepatic veno-occlusive disease (Hepatic Veno-Occlusive Disease, VOD). Hepatic veno-occlusive disease is a rare but serious disease commonly associated with hematopoietic stem cell transplantation. Defibrotide/Defibrotide SodiumThrough anticoagulation, improving vascular permeability and anti-inflammatory effects, it helps reduce blood flow obstruction in the liver, thereby alleviating symptoms such as abnormal liver function, hepatomegaly, ascites and bleeding. Although Defibrotide/Defibrotide Sodium has shown therapeutic effects on hepatic veno-occlusive disease in some studies and clinical applications, its effects vary depending on individual patient differences, disease severity and other factors. The treatment process may be accompanied by some side effects and risks, so before using Defibrotide/Defibrotide Sodium, you should obtain full evaluation and advice from your doctor. Patients should closely cooperate with medical monitoring when using Defibrotide/Defibrotide Sodium to ensure the best therapeutic effect and safety.